Skip to main content
Wolters Kluwer - PMC COVID-19 Collection logoLink to Wolters Kluwer - PMC COVID-19 Collection
. 2021 Jan 12;90(4):e72–e80. doi: 10.1097/TA.0000000000003073

Personal protective equipment for reducing the risk of COVID-19 infection among health care workers involved in emergency trauma surgery during the pandemic: An umbrella review

Reviewed by: Dylan P Griswold 1, Andres Gempeler 1, Angelos Kolias 1, Peter J Hutchinson 1, Andres M Rubiano 1
Bogotá, Colombia
PMCID: PMC7996059  PMID: 33433175

Supplemental digital content is available in the text.

KEY WORDS: Umbrella review, broad evidence synthesis, COVID-19, global health, trauma surgery, evidence-based practice, PPE, N95 masks

BACKGROUND

Health care facilities in low- and middle-income countries are inadequately resourced to adhere to current COVID-19 prevention recommendations. Recommendations for surgical emergency trauma care measures need to be adequately informed by available evidence and adapt to particular settings. To inform future recommendations, we set to summarize the effects of different personal protective equipment (PPE) on the risk of COVID-19 infection in health personnel caring for trauma surgery patients.

METHODS

We conducted an umbrella review using Living Overview of Evidence platform for COVID-19, which performs regular automated searches in MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and more than 30 other sources. Systematic reviews of experimental and observational studies assessing the efficacy of PPE were included. Indirect evidence from other health care settings was also considered. Risk of bias was assessed with the AMSTAR II tool (Assessing the Methodological Quality of Systematic Reviews, Ottawa, ON, Canada), and the Grading of Recommendations, Assessment, Development, and Evaluation approach for grading the certainty of the evidence is reported (registered in International Prospective Register of Systematic Reviews, CRD42020198267).

RESULTS

Eighteen studies that fulfilled the selection criteria were included. There is high certainty that the use of N95 respirators and surgical masks is associated with a reduced risk of COVID-19 when compared with no mask use. In moderate- to high-risk environments, N95 respirators are associated with a further reduction in risk of COVID-19 infection compared with surgical masks. Eye protection also reduces the risk of contagion in this setting. Decontamination of masks and respirators with ultraviolet germicidal irradiation, vaporous hydrogen peroxide, or dry heat is effective and does not affect PPE performance or fit.

CONCLUSION

The use of PPE drastically reduces the risk of COVID-19 compared with no mask use in health care workers. N95 and equivalent respirators provide more protection than surgical masks. Decontamination and reuse appear feasible to overcome PPE shortages and enhance the allocation of limited resources. These effects are applicable to emergency trauma care and should inform future recommendations.

LEVEL OF EVIDENCE

Review, level II.


Many health care facilities in low- and middle-income countries are inadequately resourced. COVID-19 has the potential to decimate these already strained surgical health care services unless health systems take stringent measures to protect health care workers (HCWs) from viral exposure. A recent study showed that 15.6% of confirmed COVID-19 patients are symptomatic and that nearly half of patients with no symptoms at detection time will develop symptoms later.1 These factors impede and confound diagnostic triage. Improper infection prevention may create a “super-spreader” event in a high-volume health care facility or reduce available personnel. Consequently, the infection control strategy of trauma surgery staff is a top priority.

Personal protective equipment (PPE) is paramount to protect HCWs from contracting the virus and becoming disease carriers. Basic recommended PPE for trauma surgery staff of high-income country facilities include the following: (1) a surgical mask or better for all personnel interacting with patients and in the operating room (including cleaning staff), (2) N95 or better mask for all staff in close contact with the patients (<6 ft away), (3) powered air purifier respirators (PAPRs) for aerosolizing and high-risk procedures (ear, nose, throat, thoracic, and transsphenoidal neurosurgery operations); (4) universal testing of patients preoperatively to enable appropriate PPE use, and (5) changing scrubs after every procedure.2 These recommendations are suitable for high-resource settings but are less feasible in low-resource settings. A rapid-turnaround survey of 40 health care organizations across 15 LMICs revealed that 70% lack PPE and COVID-19 testing kits and only 65% of the respondents showed confidence in hospital staff’s knowledge about precautions to be taken to prevent COVID-19 infection among hospital personnel.3 Some resource-adjusted recommendations include the use of cloth masks and bandanas. While innovative, their moisture retention, reusability, and filtration are considered inferior to N95 and other masks.4 What is most needed are evidence-based recommendations for PPE use in LMIC surgical systems where resources are either limited or unavailable. Health care workers have been instructed to consider refraining from caring for patients in the absence of adequate PPE availability.

Evidence of the efficacy of different PPE in emergency trauma surgery setting is needed to adequately adapt recommendations of PPE use to limited resources environments. A preliminary search of International Prospective Register of Systematic Reviews, MEDLINE, the Cochrane Database of Systematic Reviews, and the JBI Database of Systematic Reviews and Implementation Reports did not find any completed or ongoing systematic reviews on the topic. The primary objective of the review was to summarize the effects of different PPE in reducing the risk of COVID-19 infection of health personnel caring for patients undergoing trauma surgery. The purpose of the review was to inform recommendations for the rational use of PPE in emergency surgery staff, particularly in low-resource environments where PPE shortages and high costs are expected to hamper the safety of HCWs and affect the care of trauma patients.

PATIENTS AND METHODS

We conducted a broad evidence synthesis (umbrella review) to summarize the effects of PPE on the risk of COVID-19 infection in HCWs caring for patients in need of emergency surgery because of trauma. A protocol of this review following the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement was registered in the International Prospective Register of Systematic Reviews (CRD42020198267). This review was conducted following the JBI methodology for systematic reviews.5

Selection Criteria

Participants

We considered studies that included HCWs in emergency trauma surgery settings during the COVID-19 pandemic. Given the likelihood that reports on this specific population were scarce or even nonexistent, we also included studies of HCWs in any procedural and in-hospital setting, such as the operating room, the emergency department, and critical care units. Furthermore, indirect evidence from other viral respiratory diseases (especially severe acute respiratory syndrome [SARS] and Middle East respiratory syndrome [MERS]) was considered if summarized and discussed regarding the COVID-19 pandemic.

Intervention(s)

Different types of PPE were used while caring for patients in hospital settings (preferably in emergency surgery).

Comparator(s)

Comparators of interest were no PPE use and different types of PPE.

Outcomes

The primary outcome of interest was the risk of contagion to health personnel involved in the care of the described population during the COVID-19 pandemic, expressed as incidence, or with association measures such as risk ratios or odds ratio (OR) when compared with different PPEs or no-PPE.

Types of Studies

This review considered systematic reviews of experimental and observational studies, and experimental or observational studies if not included in systematic reviews that fulfilled population and intervention criteria. Only studies published in English or Spanish were included. We included preprint studies identified in our search, but no ongoing studies were considered.

Search Strategy

We conducted searches in the Living Overview of Evidence platform for COVID-19. The platform was consulted on July 27, 2020, using the following entries: (1) prevention or treatment, procedures, protective measures, and PPE plus population filter: COVID-19; (2) prevention or treatment, procedures, protective measures, PPE plus population filter: health workers.

Information Sources

The databases to be searched include the Living Overview of Evidence platform for COVID-19, a system that performs automated regular searches in PubMed, Embase, Cochrane Central Register of Controlled Trials, and more than 30 other sources. When compared with manual searches, this platform consistently identifies all the available studies associated with the terms of interest. It allows for a fast (automated) search that is easy to update, a crucial element given the urgent need to answer the research question rapidly and thoroughly.

Study Selection

Following the search, all identified citations were collated and uploaded into EndNoteX9 (Clarivate Analytics, PA). The citations were then imported into JBI SUMARI for the review process. Two independent reviewers examined titles and abstracts for eligibility. Full-text review verified fulfillment of selection criteria. All decisions taken during screening were documented and are outlined in this report with a list of excluded studies. Any disagreements that arose between the reviewers were solved by consensus. The results of the search are presented in a Preferred Reporting Items for Systematic Reviews and Meta-analyses flow diagram (Fig. 1).6

Figure 1.

Figure 1

Preferred Reporting Items for Systematic Reviews and Meta-analyses search results, study selection, and inclusion process.

Assessment of Methodological Quality

Eligible studies were critically appraised by a reviewer and verified by a second reviewer using the AMSTAR tool (Assessing the Methodological Quality of Systematic Reviews, Ottawa, ON, Canada). The risk of bias was assessed for only the primary outcome: infection of HCWs by COVID-19 or similar. The results of the critical appraisal are reported narratively and are considered for discussion of results.

All included studies, regardless of their risk of bias, underwent data extraction and synthesis.

Data Extraction

Data were extracted from the included studies by a reviewer and verified by a second reviewer using a data extraction tool from JBI SUMARI.5

The data extracted include specific details about the populations, study methods, interventions, and outcomes of significance to the review question and specific objectives. Disagreements were solved by consensus.

Data Synthesis

Studies were summarized narratively considering their scope, number of included studies, and risk of bias. Effect sizes from systematic reviews and individual studies not included in them are expressed as ORs (for dichotomous data) with their 95% confidence intervals (CIs).

Assessing Certainty in the Findings

The Grading of Recommendations, Assessment, Development, and Evaluation approach for grading the certainty of the evidence was followed. Grading the certainty of the evidence was not undertaken if adaptation from the identified reviews using the Grading of Recommendations, Assessment, Development, and Evaluation approach was considered complete and adequate.7,8 The certainty of the evidence was considered for interpretation and discussion of findings.

RESULTS

Study Inclusion

The study selection process is illustrated in Figure 1.6 The described search identified a total of 258 records. After title and abstract screening, 78 studies were considered for full-text review, of which 60 were excluded. Reasons for exclusion were as follows: wrong study design (n = 30),938 wrong intervention (n = 23),3960 wrong outcomes (n = 1),61 wrong language (n = 5),6266 and wrong patient population (n = 2).67,68 This left 18 studies for appraisal, extraction, and synthesis.4,6984

Appendix I (http://links.lww.com/TA/B877) shows a list of the 60 excluded studies, with reasons for their exclusion. Studies excluded because of wrong study design were mostly narrative reviews, guideline recommendations, and case reports. Wrong setting was the reason for exclusion when studies were developed in a nonhospital or community setting. Studies that did not report data related to COVID-19 contagion in HCWs were also excluded.

Included Studies

Seventeen of the 18 included studies were systematic reviews,4,6972,74,75,7781,83,85 and 1 was a qualitative evidence synthesis.83 Appendix II (http://links.lww.com/TA/B878) provides details of the characteristics of the included studies. All but one study was published in 2020.77 Data extracted from reviews included thousands of participants from 35 different countries.

Ten of 17 systematic reviews evaluated the risk of contagion for respiratory viral infections,4,33,7072,76,80,82 of which 6 included outcome data for COVID-19 infection.4,70,74,76,80,82,84

Four systematic reviews71,74,77,79 evaluate other respiratory pathogens such as seasonal influenza, SARS, H1N1, and MERS.

Methodological Quality

Tables 1 and 2 show the results of the risk of bias assessment of the included studies. Overall, the methodological quality of the 18 included studies was assessed as moderate to high by JBI appraisal standards, and no disagreements occurred between the reviewers. Of the 17 included systematic reviews, 9 had low risk of bias overall (fulfilled all indicators),70,71,7477,79,80,82 and 5 had concerns in 1 indicator,69 because of not performing risk of bias assessment. Two reviews had risk of bias in more domains,72,84 having no method of study appraisal and no method for minimizing errors in data extraction, and failing to report a risk of bias assessment. One review only fulfilled four indicators83; in addition to failing in the aforementioned indicators, it lacked future directives and recommendations for policy and clinical practice. All systematic reviews clearly stated the review question, applied appropriate inclusion criteria, and search strategy. Several reviews chose not to combine studies for meta-analysis because of study limitations and heterogeneity in study designs, comparisons, and analyses. Our search also found a qualitative research synthesis with low risk of bias overall.83

TABLE 1.

Qualitative Research

Citation Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10
Houghton et al.,73 2020 Y Y Y Y Y Y Y Y Y Y
% 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0

TABLE 2.

Systematic Reviews

Citation Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11
Abdelrahman et al.,69 2020 Y Y Y Y Y U Y Y N Y Y
Ana et al.,70 2020 Y Y Y Y Y Y Y Y Y Y Y
Bartoszko et al.,71 2020 Y Y Y Y Y Y Y Y Y Y Y
Carl-Etienne et al.,72 2020 Y Y Y Y N N N N/A N/A Y Y
Chou et al.,4 2020 Y Y Y Y Y Y Y N/A N/A Y Y
Chu et al.,82 2020 Y Y Y Y Y Y Y Y Y Y Y
Toomey et al.,85 2020 Y Y Y Y Y Y Y N/A N/A Y Y
Fouladi et al.,83 2020 Y Y Y Y N/A N/A N/A N/A N/A N N/A
Iannone et al.,74 2020 Y Y Y Y Y Y Y Y Y Y Y
O’Hearn et al.,75 2020 Y Y Y Y Y Y Y Y Y Y Y
Liang et al.,76 2020 Y Y Y Y Y Y Y Y Y Y Y
MacIntyre and Chughtai,84 2020 Y Y Y Y N N/A N N/A N/A Y Y
Offeddu et al.,77 2017 Y Y Y Y Y Y Y Y Y Y Y
Prashanth et al.,78 2020 Y Y Y Y Y Y Y N/A N/A Y Y
Tom et al.,79 2020 Y Y Y Y Y Y Y Y Y Y Y
Verbeek et al.,80 2020 Y Y Y Y Y Y Y Y Y Y Y
Zorko et al.,81 2020 Y Y Y Y Y Y Y N/A N/A Y Y
% 100.0 100.0 100.0 100.0 82.35 76.47 82.35 58.82 52.94 94.11 94.11

N, no; Q, question; U, unclear; Y, yes.

Review Findings

We did not identify comparative studies of PPE effect on the risk of COVID-19 contagion in the emergency surgery setting. We did identify systematic reviews of observational studies of COVID-19 in HCW as well as of experimental and observational studies that also addressed this question in HCWs regarding other coronavirus epidemics (SARS and MERS epidemics) considered generalizable to the COVID-19 pandemic. Some studies also assessed and summarized evidence from other viral respiratory illnesses, such as H1N1 or influenza, and reported results consistent with those of the coronaviruses outbreaks.

A high-quality systematic review that evaluated the effect of physical distancing face masks and eye protection on preventing COVID-19 contagion included 172 studies, considering evidence from COVID-19, MERS, and SARS.82 Regarding the use of eye protection, pooled analysis of 13 unadjusted and 2 adjusted studies suggested a reduced risk of contagion with eye protection compared with no eye protection (unadjusted respiratory rate [RR], 0.34; 95% CI, 0.22–0.52; adjusted OR, 0.22; 95% CI, 0.12–0.39). Regarding masks, the authors identified 30 comparative studies that focused on the effect of different masks and respirators on virus transmission in HCWs or patients and 13 studies that addressed the same effect for eye protection. They report that the use of a surgical mask compared with no face mask was associated with a considerable reduction in risk of contagion (OR, 0.33; 95% CI, 0.17–0.61). An even larger effect was seen when comparing N95 and N95 equivalent respirators to no mask (OR, 0.04; 95% CI, 0.004–0.30). Such estimates are based on studies, including a total of 12,817 participants. Adjusted and unadjusted studies were considered, and both estimates were consistent with the mentioned effect on contagion risk reduction when considering N95 or surgical/medical masks versus no mask (adjusted OR, 0.15 (0.07–0.34); unadjusted RR, 0.34 (95% CI, 0.26–0.45). Evidence for the precisely estimated reduction was rated as low by the authors, given some inconsistency and risk of bias. Nevertheless, the beneficial effect of mask protection was large, and they considered it of high certainty.82 They report that N95 had a stronger protective association compared with surgical masks or 12- to 16-layer cotton masks and both N95 and surgical masks also had a stronger association with protection versus single-layer masks. This review was considered pivotal because of the high number of included studies, the recent date of publication, and the adequacy of methods and reporting. Challenges reported in the studies included frequent discomfort, high resource use, less clear communication, and perceived reduced empathy of care providers by their patients.82

A rapid systematic review that also addressed the effect of masks to prevent COVID-19 infection considered evidence from the current pandemic in addition to the SARS and MERS epidemics.4 The review reports a reduction of risk of transmission associated with the use of masks in general. It suggests a more significant reduction associated with N95 respirators compared with surgical masks in the hospital setting (an effect seen for COVID-19 independently, as well as with the other coronaviruses outbreaks).

Other reviews considered evidence from viral respiratory illnesses, including influenza or H1N1, and report a beneficial effect of PPE (medical masks or N95 respirators) on contagion risk reduction.71,74,76,77,79,84 One of these reviews reports that the use of masks by HCWs and non-HCWs can reduce the risk of respiratory virus infection by 80% compared with no-mask (OR, 0.20; 95% CI, 0.11–0.37).76 Furthermore, respirators were found to be more protective than surgical masks, and surgical masks more protective than cloth masks.84 There appears to be no difference between respirators and medical masks when used in non–aerosol-generating procedures low-risk environments.71,79 Conversely, no significant evidence was found that supported an equivalence claim of medical masks with respirators in their level of protection against COVID-19 or other similar viruses.78 In moderate- and high-risk hospital settings, N95 is associated with more significant reductions in risk of contagion.4,84

A systematic review based on experimental designs only found that N95 respirators halve the risk of any respiratory illness compared with surgical masks; the certainty of the evidence was low because of baseline differences, indirectness of evidence for COVID-19, and low event rates that account for imprecision.74 The reduction in contagion risk calculated from 2 RCTs was estimated to be as follows: RR, 0.43; 95% CI, 0.29 to 0.64; and I2 = 0%, from pooled analysis, with an absolute effect of preventing 73 (95% CI, 91–46) more infections per 1000 HCWs wearing N95 respirators compared with surgical masks.74

Among the included studies, one reported on the use of PAPRs.70 Based on observational studies, the authors report that they did not find a difference in risk of contagion in HCWs when comparing PAPR devices with other more compliant protective elements (N95, FFP2). They found that PAPR users reported higher heat tolerance but limited mobility and reduced audibility.

Regarding decontamination, a systematic review assessed the effectiveness of ultraviolet germicidal irradiation for the decontamination of PPE and its impact on PPE performance.75 Its findings support that the use of a cumulative ultraviolet-C dose of at least 40,000 J/m2 results in adequate decontamination without affecting performance or fit afterward. Another review on the subject reported that mask (N95) performance was best conserved using dry heat decontamination and that vaporous hydrogen peroxide and ultraviolet germicidal irradiation are effective decontaminants. However, its effect on surgical masks is unknown.81 The authors also state that bleach is not safe for decontamination since it alters mask performance and might be associated with health risk for users.

A qualitative evidence synthesis that searched for barriers and facilitators of HCWs adherence to PPE protocols included 20 studies of moderate- to high-quality overall (10 from Asia, 4 from Africa, 4 from Central and North America, and 2 from Australia).73 They report that HCWs were unsure to follow recommendations when they are long and ambiguous or do not reflect national or international guidelines. Some were overwhelmed because of constantly changing guidelines and by the increased workload and fatigue associated with PPE use because of preparation and cleaning. A serious concern was the lack of PPE or the low quality of the available items, pointing at a need to adjust supplies during the pandemic. Health care workers reported that it was challenging to use masks and other equipment when it made patients feel isolated, frightened, or stigmatized. Of course, discomfort associated with wearing PPE was also reported.

DISCUSSION

Our review aimed at summarizing the available evidence of the effect of different PPE on the risk of COVID-19 infection among HCWs caring for patients requiring urgent trauma assessment and surgical care. We did not find experimental studies that assessed PPE on emergency trauma surgery settings during the pandemic. Limited observational evidence from COVID-19, indirect evidence from other health care settings, and other viral outbreaks were all considered to answer our research question given that the population (HCW) and intervention (PPE) of interest were the same and thus considered applicable to the emergency surgery setting.

The available evidence was consistent to show that the use of N95 respirators and surgical masks is associated with a reduced risk of coronaviruses respiratory illness compared with no mask use, with high certainty on this beneficial effect.4,82 In moderate- to high-risk environments, especially in aerosol-generating procedures, evidence suggests that N95 respirators are associated with a more significant reduction in risk of COVID-19 infection compared with surgical masks, an effect seen in observational COVID-19 studies and experimental viral respiratory illness studies. Low-quality evidence estimates from these studies suggest a relative reduction of 50% in the risk of contagion associated with N95 respirators compared with surgical masks. Eye protection also significantly reduces the risk of contagion compared with no-eye protection. Furthermore, the decontamination of masks and respirators with ultraviolet germicidal irradiation, vaporous hydrogen peroxide, or dry heat is effective and does not affect PPE performance or fit. This evidence should inform decontamination and reuse protocols to avoid shortages and enhance resource allocation and use. The costs associated with additional protective measures during the COVID-19 pandemic could be significant and affect health care institutions in low- and middle-income countries. The cost-effectiveness of interventions must also be taken into consideration to generate recommendations during the current pandemic. The possibility to decontaminate and reuse different types of masks can be determined in shortages and will probably reduce costs without affecting HCW’s safety.

In a survey of 5,442 neurosurgical staff members in Hubei province, among 120 participants that were infected, 78.3% reported wearing surgical masks and 20.8% failed to use any protection when exposed to the source of infection. A total of 1,287 operated under level 2 protection, and only 1 was infected,28 further illustrating the pertinence of wearing adequate PPE when caring for surgical trauma patients.

Expert recommendations developed from a study of emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China, notes that, while PAPRs were the PPE of choice when face shields or full hoods without PAPR were substituted, there were no instances of infection of operators.10 Because the risk of virus exposure due to self-contamination is high during the removal of PPE, educational training for proper donning and doffing of PPE as well as monitoring for compliance is essential. The minimum recommended PPE is eye protection, a fit-tested respirator (N95 or FFP3), a fluid-resistant gown, and gloves. The French guidelines recommend FFP2-type protective filtering masks when performing any aerosol-generating procedures.12 Guidelines for chest compressions recommend level 3 PPE, which includes an FFP; disposable fluid-resistant gown, disposable apron, and gloves; fluid-resistant surgical mask; and eye or full-face protection.17 Recommendations for otolaryngologists include fluid-resistant FFP3/N95 mask, disposable and fluid resistant gloves, and gown, glasses, or a full face shield.14

Intubation of trauma patients is a high-risk-of-contagion procedure during the COVID-19 pandemic. A survey in 503 hospitals from 17 countries included 1,718 HCWs performing 5,148 tracheal intubations and measured a 10.7% incidence of COVID-19 infection after tracheal intubation.30 Most participants reported wearing gloves, gown, eye protection, and FFP2/FFP3/N95/N100 respirators. Simulation studies have assessed the effect of additional protective and preventive measures, such as transparent plastic boxes or PAPR, on the vision, comfort, and success of tracheal intubations.33,34

A survey of HCWs realities and perceptions during the pandemic in Latin America included 936 participants and reported low access to disposable gowns (67.3%), N95 respirators (56.1%), and facial protective shields (32.6%). Even access to disposable surgical masks was reported by only 83.9% of participants.31 This emphasizes the need for rational use of limited PPE during the pandemic in LMICs to ensure HCW safety without withholding urgent trauma care.

Our findings regarding decontamination should be considered as a feasible solution for the limited access to N95 equivalent respirators during shortages and in limited resources environments. Also, to avoid such shortages, it appears that N95 respirator equivalents use should be limited to moderate- to high-risk environments, when caring for patients with confirmed COVID-19, or for suspicious or unknown status patients who need emergency surgery because of trauma.

STRENGTHS AND LIMITATIONS

Our review used an automated search platform where evidence on COVID-19 is available. This strategy streamlined the rapid nature of the review while ensuring that all relevant studies were identified. Using an automated system has the additional long-term advantage of facilitating review updates by quickly identifying new studies that satisfy selection criteria. Our review also has the strength of having critically assessed all included studies. We report on the estimates and evidence grading of the identified high-quality systematic reviews. A metanalysis of systematic reviews results was not planned in our review protocol and was not considered adequate, given the overlap of included studies among reviews and the variation in selection criteria. Despite the differences between reviews, the consistency of findings among the reviews provides high certainty of the beneficial effects of PPE in the hospital setting. The main limitation of our review is that evidence from our specific setting of interest, that is, emergency trauma surgery, was not identified. Nevertheless, extrapolation from other clinical settings such as the emergency room, COVID-19 wards, and critical care during the pandemic was considered adequate given the characteristics of the intervention and the similarities to the setting of interest.

CONCLUSIONS

The use of PPE drastically reduces the risk of COVID-19 compared with no mask use in HCWs in the hospital setting. Respirators like N95 or equivalent provided more protection and were found to halve the risk of COVID-19 contagion in HCWs from moderate- and high-risk settings. Eye protection also provides additional protection and is associated with reduced incidence of contagion. These effects apply to emergency trauma care. Decontamination and reuse appear as feasible measures that could help overcome PPE shortages and enhance the allocation of limited resources.

Recommendations for Practice

When caring for a trauma patient with suspected or unknown COVID-19 status, HCWs should use at least N95 respirators or equivalents to reduce the risk of COVID-19 infection adequately. Decontamination with ultraviolet light, hydrogen peroxide, and dry heat should be made available.

Recommendations for Research

Robust RCTs comparing the efficacy of surgical masks versus N95 respirators in HCWs caring for trauma patients are potentially unethical, as existing data show a significant protective effect, thus requiring emergency trauma surgery staff to wear N95 respirators when available. As of October 2020, there is a lack of consensus among international experts surrounding the topic of aerosol transmission, meaning that viral microdroplets are capable of floating in the air without being pulled down by gravity. This means that, if someone coughs, sings, or even breathes, the microdroplets can stay in stagnant air for up to 16 hours and, with normal ventilation, between 20 minutes and 4 hours. While multiple studies have discussed how SARS-coronavirus 2 can be found in aerosols, including one from May and another from April,86,87 a group of epidemiologists in late July characterized research on aerosol transmission as unconvincing and cited extensive published evidence from across the globe showing that the overwhelming majority of viral spread is via large respiratory droplets.88 The Centers for Disease Control did not acknowledge aerosol transmission as an important route for viral transmission until September 2020, placing aerosol ahead of droplet transmission as the predominant mechanism of viral spread. However, just a few days later, the statement was recalled, with updated guidelines saying HCWs need an N95 respirator for aerosol-generating procedures, only.89 The hospital administrators and epidemiologists who argue that the virus is mainly droplet spread claim N95 respirators and strict patient isolation practices are not necessary for routine care of COVID-19 patients. It is essential to develop a complete understanding of the transmissibility of SARS-coronavirus 2 because it drives two different sets of protective practices, touching on everything from airflow within hospital wards to patient isolation to choices of PPE. Enhanced protections would be expensive and disruptive and would have strong implications on costs, especially in low-resources environments. Amid the uncertainty, adopting the highest possible forms of protection seems the best course of action (Figure 2).

Figure 2.

Figure 2

Proposed general recommendations.

AUTHORSHIP

D.P.G., A.G., A.K., P.J.H., and A.M.R. contributed in the design and implementation of the research, analysis of the results, and writing of the article.

ACKNOWLEDGMENT

This work is supported by the National Institute for Health Research (NIHR) Global Health Research Group on Neurotrauma, which was commissioned by the NIHR using United Kingdom aid from the United Kingdom Government (project 16/137/105). P.J.H. is the chief investigator of the RESCUEicp and RESCUE-ASDH randomized trials. D.P.G. was supported by the Gates Cambridge Trust. P.J.H. was supported by a Research Professorship from the NIHR, the NIHR Cambridge Biomedical Research Centre, a European Union Seventh Framework Programme grant (CENTER-TBI; grant number, 602,150), and the Royal College of Surgeons of England. A.K. was supported by a Clinical Lectureship from the School of Clinical Medicine, University of Cambridge, and the Royal College of Surgeons of England.

DISCLOSURE

All authors have completed the International Committee of Medical Journal Editors uniform disclosure form and declare no support from any organization for the submitted work, no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years, and no other relationships or activities that could appear to have influenced the submitted work. The lead author (D.P.G.) affirms that this article is an honest, accurate, and transparent account of the study being reported, that no important aspects of the study have been omitted, and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.

Footnotes

Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (www.jtrauma.com).

Published online: January 6, 2021

Contributor Information

Dylan P. Griswold, Email: dylgris@gmail.com.

Andres Gempeler, Email: andres.gempeler@fvl.org.co.

Angelos Kolias, Email: ak721@cam.ac.uk.

Peter J. Hutchinson, Email: pjah2@cam.ac.uk.

REFERENCES

  • 1.Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, Zhang J, Zhao C. Clinical characteristics of 3062 COVID-19 patients: a meta-analysis. J Med Virol. 2020;92(10):1902–1914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Stewart CL, Thornblade LW, Diamond DJ, Fong Y, Melstrom LG. Personal protective equipment and COVID-19: a review for surgeons. Ann Surg. 2020;272(2):e132–e138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gonzalez N, Hatchcock A, Jansen N, Weine S. A rapid turnaround survey of COVID-19 in LMICs: the readiness, responses, and challenges of healthcare organizations. 2020. This is an online report published by, The Center for Global Health, University of Illinois at Chicago, College of Medicine, Chicago, IL. Available at: https://chicago.medicine.uic.edu/wp-content/uploads/sites/6/2020/06/A-Rapid-Turnaround-Survey-of-COVID-19-in-LMICs_White-Paper-2.pdf. Accessed September 14, 2020. [Google Scholar]
  • 4.Chou R, Dana T, Jungbauer R, Weeks C, McDonagh MS. Masks for prevention of respiratory virus infections, including SARS-CoV-2, in health care and community settings: a living rapid review. Ann Intern Med. 2020;173(7):542–555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Aromataris E, Munn Z, Tufanaru C, Campbell J, Hopp L. JBI Reviewer’s Manual. Adelaide, Australia: Joanna Briggs Institute; 2019. [Google Scholar]
  • 6.Moher D Liberati A Tetzlaff J Altman DG, PRISMA Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–341. [DOI] [PubMed] [Google Scholar]
  • 7.Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Guyatt G Oxman AD Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–394. [DOI] [PubMed] [Google Scholar]
  • 9.Ippolito M, Vitale F, Accurso G, Iozzo P, Gregoretti C, Giarratano A, Cortegiani A. Medical masks and respirators for the protection of healthcare workers from SARS-CoV-2 and other viruses. Pulmonology. 2020;26(4):204–212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Yao W Wang T Jiang B, et al. Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations. Brit J Anaesth. 2020;125(1):e28–e37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Service BC Collins AP Crespo A, et al. Medically necessary orthopaedic surgery during the COVID-19 pandemic: safe surgical practices and a classification to guide treatment. J Bone Joint Surg Am. 2020;102(14):e76. [DOI] [PubMed] [Google Scholar]
  • 12.Lepelletier D Grandbastien B Romano-Bertrand S Aho S Chidiac C Géhanno JF Chauvin F, French Society for Hospital Hygiene and the High Council for Public Health . What face mask for what use in the context of COVID-19 pandemic? The French guidelines. J Hosp Infect. 2020;105(3):414–418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Leboulanger N Sagardoy T Akkari M, et al. COVID-19 and ENT pediatric otolaryngology during the COVID-19 pandemic. Guidelines of the French Association of Pediatric Otorhinolaryngology (AFOP) and French Society of Otorhinolaryngology (SFORL). Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137(3):177–181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Krajewska J, Krajewski W, Zub K, Zatoński T. COVID-19 in otolaryngologist practice: a review of current knowledge. Eur Arch Otorhinolaryngol. 2020;277(7):1885–1897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hirschmann MT, Hart A, Henckel J, Sadoghi P, Seil R, Mouton C. COVID-19 coronavirus: recommended personal protective equipment for the orthopaedic and trauma surgeon. Knee Surg Sports Traumatol Arthrosc. 2020;28(6):1690–1698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Garcia Godoy LR, Jones AE, Anderson TN, Fisher CL, Seeley KML, Beeson EA, Zane HK, Peterson JW, Sullivan PD. Facial protection for healthcare workers during pandemics: a scoping review. BMJ Glob Health. 2020;5(5):e002553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Brown E, Chan LM. Should chest compressions be considered an aerosol-generating procedure? A literature review in response to recent guidelines on personal protective equipment for patients with suspected COVID-19. Clin Med. 2020;20(5):e154–e159:clinmed.2020-0258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Malik T. COVID-19 and the efficacy of different types of respiratory protective equipment used by health care providers in a health care setting. Cureus. 2020;12(4):e7621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Chersich MF Gray G Fairlie L, et al. COVID-19 in Africa: care and protection for frontline healthcare workers. Global Health. 2020;16(1):46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hiramatsu M, Nishio N, Ozaki M, Shindo Y, Suzuki K, Yamamoto T, Fujimoto Y, Sone M. Anesthetic and surgical management of tracheostomy in a patient with COVID-19. Auris Nasus Larynx. 2020;47(3):472–476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lee S, Meyler P, Mozel M, Tauh T, Merchant R. Asymptomatic carriage and transmission of SARS-CoV-2: what do we know? Can J Anaesth. 2020;67(10):1424–1430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Winck JC, Ambrosino N. COVID-19 pandemic and non invasive respiratory management: every Goliath needs a David. An evidence based evaluation of problems. Pulmonology. 2020;26(4):213–220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Boškoski I, Gallo C, Wallace MB, Costamagna G. COVID-19 pandemic and personal protective equipment shortage: protective efficacy comparing masks and scientific methods for respirator reuse. Gastrointest Endosc. 2020;92(3):519–523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Convissar D, Berra L, Chang MG, Bittner EA. Personal protective equipment N95 facemask shortage quick fix: the modified airway from VEntilatoR circuit (MAVerIC). Cureus. 2020;12(5):e7914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Sugrue M, O’Keeffe D, Sugrue R, MacLean L, Varzgalis M. A cloth mask for under-resourced healthcare settings in the COVID19 pandemic. Ir J Med Sci. 2020;189(4):1155–1157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Heinzerling A Stuckey MJ Scheuer T, et al. Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient — Solano County, California, February 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):472–476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Jessop ZM Dobbs TD Ali SR, et al. Personal protective equipment for surgeons during COVID-19 pandemic: systematic review of availability, usage and rationing. Br J Surg. 2020;107(10):1262–1280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Qiangping W Xing H Yansen B, et al. Epidemiological characteristics of COVID-19 in medical staff members of neurosurgery departments in Hubei province: a multicentre descriptive study. medRxiv. 2020. DOI:10.1101/2020.04.20.20064899. [Google Scholar]
  • 29.Wahidi MM Shojaee S Lamb CR, et al. The use of bronchoscopy during the Coronavirus Disease 2019 pandemic: CHEST/AABIP guideline and expert panel report. Chest. 2020;158(3):1268–1281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.El-Boghdadly K Wong DJN Owen R, et al. Risks to healthcare workers following tracheal intubation of patients with COVID-19: a prospective international multicentre cohort study. Anaesthesia. 2020;75(11):1437–1447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Delgado D, Wyss Quintana F, Perez G, Sosa Liprandi A, Ponte-Negretti C, Mendoza I, Baranchuk A. Personal safety during the COVID-19 pandemic: realities and perspectives of healthcare workers in Latin America. Int J Environ Res Public Health. 2020;17(8):2798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wang X, Pan Z, Cheng Z. Association between 2019-nCoV transmission and N95 respirator use. J Hosp Infect. 2020;105(1):104–105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Clariot S, Dumain G, Gauci E, Langeron O, Levesque É. Minimising COVID-19 exposure during tracheal intubation by using a transparent plastic box: a randomised prospective simulation study. Anaesth Crit Care Pain Med. 2020;39(4):461–463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Schumacher J, Arlidge J, Dudley D, Sicinski M, Ahmad I. The impact of respiratory protective equipment on difficult airway management: a randomised, crossover, simulation study. Anaesthesia. 2020;75(10):1301–1306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Wilson JM, Schwartz AM, Farley KX, Devito DP, Fletcher ND. Doing our part to conserve resources: determining whether all personal protective equipment is mandatory for closed reduction and percutaneous pinning of supracondylar humeral fractures. J Bone Joint Surg Am. 2020;102(13):e66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Gong Y Cao X Mei W, et al. Anesthesia considerations and infection precautions for trauma and acute care cases during the COVID-19 pandemic: recommendations from a task force of the Chinese Society of Anesthesiology. Anesth Analg. 2020;131(2):326–334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Derince T, Research H. Effect of using barrier devices for intubation in COVID-19 patients. Published June 2, 2020. Available at: https://clinicaltrials.gov/ct2/show/NCT04412226. Accessed September 24, 2020.
  • 38.Mueller AV, Eden MJ, Oakes JM, Bellini C, Fernandez LA. Quantitative method for comparative assessment of particle removal efficiency of fabric masks as alternatives to standard surgical masks for PPE. Matter. 2020;3(3):950–962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Dedeilia A, Sotiropoulos MG, Hanrahan JG, Janga D, Dedeilias P, Sideris M. Medical and surgical education challenges and innovations in the COVID-19 era: a systematic review. In Vivo. 2020;34(Suppl 3):1603–1611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Jones P, Roberts S, Hotu C, Kamona S. What proportion of healthcare worker masks carry virus? A systematic review. Emerg Med Australas. 2020;32(5):823–829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Mhango M, Dzobo M, Chitungo I, Dzinamarira T. COVID-19 risk factors among health workers: a rapid review. Saf Health Work. 2020;11(3):262–265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Steven B, Nwabueze GE, Nicolas M, Bill W, Obuks E. Can we use these masks? Rapid assessment of the inhalation resistance performance of uncertified medical face masks in the context of restricted resources imposed during a public health emergency. medRxiv. 2020. DOI: 10.1101/2020.05.13.20100602. [Google Scholar]
  • 43.Malysz M Dabrowski M Böttiger BW, et al. Resuscitation of the patient with suspected/confirmed COVID-19 when wearing personal protective equipment: a randomized multicenter crossover simulation trial. Cardiol J. 2020;27(5):497–506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Islam MS, Rahman KM, Sun Y, Qureshi MO, Abdi I, Chughtai AA, Seale H. Current knowledge of COVID-19 and infection prevention and control strategies in healthcare settings: a global analysis. Infect Control Hosp Epidemiol. 2020;41(10):1196–1206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Powell-Jackson T, King JJC, Makungu C, Spieker N, Woodd S, Risha P, Goodman C. Infection prevention and control compliance in Tanzanian outpatient facilities: a cross-sectional study with implications for the control of COVID-19. Lancet Glob Health. 2020;8(6):e780–e789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Liao L, Xiao W, Zhao M, Yu X, Wang H, Wang Q, Chu S, Cui Y. Can N95 respirators be reused after disinfection? How many times? ACS Nano. 2020;14(5):6348–6356. [DOI] [PubMed] [Google Scholar]
  • 47.Szpara Derr TH, Melissa AJ, Chad VK, Prem PK, Matthew DB, Kevin LH, Mark AB, Moriah LS. Aerosolized hydrogen peroxide decontamination of N95 respirators, with fit-testing and Virologic confirmation of suitability for re-use during the COVID-19 pandemic. medRxiv. 2020. DOI: 10.1101/2020.04.17.20068577. [Google Scholar]
  • 48.Cadnum JL, Li DF, Redmond SN, John AR, Pearlmutter B, Donskey CJ. Effectiveness of ultraviolet-C light and a high-level disinfection cabinet for decontamination of N95 respirators. Pathog Immun. 2020;5(1):52–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Zhong H, Zhu Z, Lin J, Cheung CF, Lu VL, Yan F, Chan CY, Li G. Reusable and recyclable graphene masks with outstanding superhydrophobic and photothermal performances. ACS Nano. 2020;14(5):6213–6221. [DOI] [PubMed] [Google Scholar]
  • 50.Konda A, Prakash A, Moss GA, Schmoldt M, Grant GD, Guha S. Aerosol filtration efficiency of common fabrics used in respiratory cloth masks. ACS Nano. 2020;14(5):6339–6347. [DOI] [PubMed] [Google Scholar]
  • 51.Roland L, Guillaume L. Effect of ethanol cleaning on the permeability of FFP2 mask. medRxiv. 2020. DOI: 10.1101/2020.04.28.20083840. [Google Scholar]
  • 52.Christensen L, Rasmussen CS, Benfield T, Franc JM. A randomized trial of instructor-led training versus video lesson in training health care providers in proper donning and doffing of personal protective equipment. Disaster Med Public Health Prep. 2020;14:514–520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Cramer A, Plana D, Yang HL, Carmack M, Tian E, Sinha MS, Krikorian D, Turner D, Mo J, Li J, Gupta R, Manning H, Bourgeois FT, Yu SH, Sorger P, LeBoeuf NR. Analysis of SteraMist ionized hydrogen peroxide technology in the sterilization of N95 respirators and other PPE: a quality improvement study. medRxiv. 2020;2020.04.19.20069997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Sarah S Carrion JrR Kendra A, et al. Disinfection effect of pulsed xenon ultraviolet irradiation on SARS-CoV-2 and implications for environmental risk of COVID-19 transmission. medRxiv. 2020. DOI: 10.1101/2020.05.06.20093658. [Google Scholar]
  • 55.Simeon CD Niclas M Kariym J, et al. Thermal disinfection inactivates SARS-CoV-2 in N95 respirators while maintaining their protective function. medRxiv. 2020. doi: 10.1101/2020.05.25.20112615. [Google Scholar]
  • 56.Ebru O Keith KW Rachel LC, et al. Vapor H2O2 sterilization as a decontamination method for the reuse of N95 respirators in the COVID-19 emergency. medRxiv. 2020. doi: 10.1101/2020.04.11.20062026. [Google Scholar]
  • 57.Massey T, Borucki M, Paik S, Fuhrer K, Bora M, Kane S, Haque R, Baxamusa SH. Quantitative form and fit of N95 filtering facepiece respirators are retained and coronavirus surrogate is inactivated after heat treatments. medRxiv. 2020. doi: 10.1101/2020.04.15.20065755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Avilash C, Enze T, Sherryl HY, Mitchell G, Edward L, Ju L, Rajiv G, Michael PS. Disposable N95 masks pass qualitative fit-test but have decreased filtration efficiency after Cobalt-60 gamma irradiation. medRxiv. 2020. doi: 10.1101/2020.03.28.20043471. [Google Scholar]
  • 59.Rubin GD Ryerson CJ Haramati LB, et al. The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner Society. Chest. 2020;158(1):106–116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Zulauf KE, Green AB, Nguyen Ba AN, Jagdish T, Reif D, Seeley R, Dale A, Kirby JE. Microwave-generated steam decontamination of N95 respirators utilizing universally accessible materials. mBio. 2020;11(3):e00997–e00920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Canova V, Lederer Schläpfer H, Piso RJ, Droll A, Fenner L, Hoffmann T, Hoffmann M. Transmission risk of SARS-CoV-2 to healthcare workers—observational results of a primary care hospital contact tracing. Swiss Med Wkly. 2020;150:w20257. [DOI] [PubMed] [Google Scholar]
  • 62.Schnitzbauer AA, Kempf VAJ, Hack D, Ciesek S, Meier S, Vehreschild MJGT, Wicker S, Kippke U, Graf J, Marzi I. SARS-CoV-2/COVID-19: systematic review of requirements for personal protective equipment in primary patient contact and organization of the operating area. Chirurg. 2020;91(7):576–585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Parreira PCL Medeiros FC Brito GV, et al. Personal protective masks for COVID-19 prevention: quick systematic review. 2020.
  • 64.ANVISA . Guidelines for health services: prevention and control measures that should be adopted when assisting suspected or confirmed cases of infection with the new coronavirus (SARS-CoV-2). Published March 30, 2020. Available at: http://portal.anvisa.gov.b/ocument/385/7185/ota+T%C3%A9cnica+n+04-2020+GVIMS-GGTES-ANVISA-ATUALIZAD/b598660-3de4-4f14-8e6f-b9341c196b28. Accessed September 17, 2020.
  • 65.Perú. EsSalud . Instituto de Evaluación de Tecnologías en Salud e Investigación. Comparison of surgical (medical) masks with respirators to prevent SARS-COV-2 infection in health personnel to COVID-19. Available at: https://docs.bvsalud.org/biblioref/2020/05/1096646/rb-24respirador-vs-mask_04mayo.pdf. Accessed September 17, 2020.
  • 66.Comité Provincial de Biotecnología de la Provincia de Neuquén . Use of face masks in the context of the COVID-19 pandemic in the Neuquén Health System. https://docs.bvsalud.org/biblioref/2020/04/1094953/macaras_faciales_covid19.pdf. Accessed September 17, 2020.
  • 67.Gralton J, McLaws ML. Protecting healthcare workers from pandemic influenza: N95 or surgical masks? Crit Care Med. 2010;38(2):657–667. [DOI] [PubMed] [Google Scholar]
  • 68.Suzanne BJ, Natalia J, Iain L, Lee H, Paul H. Facemasks and similar barriers to prevent respiratory illness such as COVID-19: a rapid systematic review. medRxiv. 2020. DOI: 10.1101/2020.04.01.20049528. [Google Scholar]
  • 69.Welsh Surgical Research Initiative (WSRI) Collaborative. Recommended operating room practice during the COVID‐19 pandemic: systematic review. Bjs Open. 2020;4(5):748–756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Licina A, Silvers A, Stuart RL. Use of powered air-purifying respirator(PAPR) by healthcare workers for preventing highly infectious viral diseases — a systematic review of evidence. Syst Rev. 2020;9(1):173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Bartoszko JJ, Farooqi MAM, Alhazzani W, Loeb M. Medical masks vs N95 respirators for preventing COVID-19 in healthcare workers: a systematic review and meta-analysis of randomized trials. Influenza Other Respir Viruses. 2020;14(4):365–373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Carl-Etienne J, Toma P, Matt B, Genevieve G, Louise P. Evidence-based, cost-effective interventions to suppress the COVID-19 pandemic: a rapid systematic review. Medrxiv. 2020. DOI: 10.1101/2020.04.20.20054726. [Google Scholar]
  • 73.Houghton C, Meskell P, Delaney H, Smalle M, Glenton C, Booth A, Chan XHS, Devane D, Biesty LM. Barriers and facilitators to healthcare workers’ adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis. Cochrane Database Syst Rev. 2020;4(4):CD013582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Iannone P Castellini G Coclite D, et al. The need of health policy perspective to protect healthcare workers during COVID-19 pandemic. A GRADE rapid review on the N95 respirators effectiveness. Plos One. 2020;15(6):e0234025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.O’Hearn K Gertsman S Sampson M, et al. Decontaminating N95 and SN95 masks with ultraviolet germicidal irradiation does not impair mask efficacy and safety. J Hosp Infect. 2020;106(1):163–175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Liang M, Gao L, Cheng C, Zhou Q, Uy JP, Heiner K, Sun C. Efficacy of face mask in preventing respiratory virus transmission: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;36:101751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Offeddu V, Yung CF, Low MSF, Tam CC. Effectiveness of masks and respirators against respiratory infections in healthcare workers: a systematic review and meta-analysis. Clin Infect Dis. 2017;65(11):1934–1942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Ramaraj P, Super J, Doyle R, Aylwin C, Hettiaratchy S. Triaging of respiratory protective equipment on the assumed risk of SARS-CoV-2 aerosol exposure in patient-facing healthcare workers delivering secondary care: a rapid review. BMJ Open. 2020;10(10):e040321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Tom J Mark J Lubna AAA, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Part 1 — face masks, eye protection and person distancing: systematic review and meta-analysis. Medrxiv. 2020. DOI: 10.1101/2020.03.30.20047217. [Google Scholar]
  • 80.Verbeek JH, Rajamaki B, Ijaz S, Sauni R, Toomey E, Blackwood B, Tikka C, Ruotsalainen JH, Kilinc Balci FS. Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. Cochrane Database Syst Rev. 2020;5:CD011621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Zorko DJ, Gertsman S, O’Hearn K, Timmerman N, Ambu-Ali N, Dinh T, Sampson M, Sikora L, McNally JD, Choong K. Decontamination interventions for the reuse of surgical mask personal protective equipment: a systematic review. J Hosp Infect. 2020;106(2):283–294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Chu DK Akl EA Duda S, COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395(10242):1973–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Fouladi Dehaghi B, Ghodrati-Torbati A, Teimori G, Ibrahimi Ghavamabadi L, Jamshidnezhad A. Face masks vs. COVID-19: a systematic review. Invest Educ Enferm. 2020;38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.MacIntyre CR, Chughtai AA. A rapid systematic review of the efficacy of face masks and respirators against coronaviruses and other respiratory transmissible viruses for the community, healthcare workers and sick patients. Int J Nurs Stud. 2020;108:103629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Toomey EC, Conway Y, Burton C, Smith S, Smalle M, Chan X-HS, Adisesh A, Tanveer S, Ross L, Thomson I, Devane D, Greenhalgh T. Extended use or reuse of single-use surgical masks and filtering face-piece respirators during the coronavirus disease 2019 (COVID-19) pandemic: a rapid systematic review. Infect Control Hosp Epidemiol. 2021;42(1):75–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Somsen GA, van Rijn C, Kooij S, Bem RA, Bonn D. Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission. Lancet Respir Med. 2020;8(7):658–659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.van Doremalen N Bushmaker T Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–1567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.O'Donnell J. Penn Medicine statement on the question of droplet or airborne transmission of SARS-CoV-2. Medicine P, ed. Published online July 23, 2020. Available at: http://image.www2.pennmedicine.org/lib/fe2d117170640478711179/m/1/d6cef08a-993b-4f2f-b2c9-8a89b8bcf373.pdf?utm_medium=Email&utm_source=SFMC. Accessed September 24, 2020.
  • 89.Prevention C for DC and. How COVID-19 spreads. Published September 21, 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html. Accessed September 24, 2020.

Articles from The Journal of Trauma and Acute Care Surgery are provided here courtesy of Wolters Kluwer Health

RESOURCES